Stockreport

Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance

CareDx, Inc.  (CDNA) 
Last caredx, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.caredxinc.com
PDF First Study to Establish AlloSure Lung dd-cfDNA Baseline Beyond Two Years Post-Transplant by Evaluating Clinically Stable Patients BRISBANE, Calif.--(BUSINESS WIRE)-- [Read more]